Cure8 research brief
Validated, language‑adapted questionnaires let clinicians and researchers measure disease control and quality of life reliably. A Persian IBDcQ-8 helps include Persian‑speaking patients in clinical care and research and supports remote (telephone) assessment.
Persian‑speaking adult patients with IBD, clinicians assessing disease control or quality of life, researchers planning outcomes or PROMs in IBD studies, and trial teams needing validated Persian instruments.
This study reports validation of the Persian translation of the 8‑item Inflammatory Bowel Disease control Questionnaire (IBDcQ-8) in an Iranian IBD sample.
The authors used forward–backward translation, content review by evaluators, and compared IBDcQ-8 scores with clinical indices (Harvey‑Bradshaw Index, partial Mayo), the IBDQ, CRP, and clinician assessment. Test–retest reliability was measured at one day and two weeks, and correlations with comparator measures were reported.
The abstract indicates the Persian IBDcQ-8 correlated strongly with HBI and IBDQ and moderately with partial Mayo score, CRP, and clinical evaluation. Short‑interval (one day) agreement was excellent (ICC=0.82) and two‑week agreement was moderate (ICC=0.61).
The authors conclude the Persian tool shows robust validity and acceptable reliability, including when administered by telephone. This is an abstracted validation study rather than an interventional trial; it describes questionnaire performance characteristics in a sample of 101 patients (about two‑thirds UC).
The brief is grounded in the article abstract provided and does not represent review of a full paper beyond the supplied text.
This classification is based on the article abstract. Validation studies report psychometric properties in the sampled population but do not by themselves change clinical care. The study sample was 101 patients (66% UC); performance may vary in different settings or subgroups.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study tests whether a simple blood-derived index (CRP×NLR) can help identify moderate-to-severe endoscopic inflammation when timely endoscopy is limited in hospitalized UC patients.
Blood-based inflammatory ratios like CRP/albumin were associated with higher odds of needing anti‑TNF therapy, colectomy, and longer hospital stays in moderate–severe UC, suggesting potential utility as complementary...
People hospitalized with ulcerative colitis who don’t meet classic severe-disease criteria can still face meaningful colectomy risk. Using a lower CRP cutoff might help clinicians identify more high-risk patients...
